| 1. Biotechnology: The Challenge.
Proceedings of the USDA Biotechnology Challenge Forum, Washington D.C.
February 5-6, 1987 Summary of the proceedings of the United States Department of Agriculture’s Challenge Forum of 1987 on the future of biotechnology. The forum’s goals were to increase public knowledge about agricultural biotechnology research and to examine the role of the Federal Government in regulating the result of such research. SuDoc number: A 1.2:B 56/X |
| 2. The U.S. Biotechnology Industry
(Part of the series “Meeting the Challenge: U.S. Industry Faces the 21st
Century”) 1997 This report discusses the structure of the industry and the current and emerging markets for biotechnology products, and the factors likely to be critical in determining the future competitiveness of the industry. SuDoc number: C 1.2:B 52 Online version: http://purl.gpo.gov/GPO/LPS72 |
| 3. Genetically Engineered Foods
Fears and Facts: An Interview with FDA’s Jim Maryanski An interview with the coordinator for biotechnology in FDA’s Center for Food Safety and Applied Nutrition, reprinted from FDA Consumer Magazine. SuDoc number: HE 20.4010/A:G 286/5 |
| 4. Report on National Biotechnology
Policy (1991) This report by the President’s Council on Competitiveness recommends steps to implement the goal of maintaining and improving U.S. competitiveness in biotechnology. SuDoc number: PR 41.8:B 52 |
| 5. Cloning Human Beings (1997) A two volume report from the National Bioethics Advisory Commission which outlines the scientific, religious, ethical and legal issues of cloning humans and includes recommendations by the Commission. Volume II consists of commissioned papers. SuDoc number: PREX 1.19:B 52/C 62/V.1 Online version: http://purl.access.gpo.gov/GPO/LPS439 SuDoc number: PREX 1.19:B 52/C 62/V.2 Online version: http://govinfo.library.unt.edu/nbac/pubs.html |
| 6. Research Involving Human
Biological Materials: Ethical Issues and Policy Guidance (2000) (Two volumes plus an Executive Summary) This report by the National Bioethics Advisory Commission addresses the ethical issues and issues of individual privacy raised by the ability of biomedical researchers to study human biological materials. SuDoc number: PREX 1.19:B 52/ET 3/EXEC.SUM SuDoc number: PREX 1.19:B 52/ET 3/V.1 Online version: http://purl.access.gpo.gov/GPO/LPS26174 SuDoc number: PREX 1.19:B 52/ET 3/V.2 Online version: http://purl.access.gpo.gov/GPO/LPS26175 |
| 6. Research Involving Human
Biological Materials: Ethical Issues and Policy Guidance (2000) (Two volumes plus an Executive Summary) This report by the National Bioethics Advisory Commission addresses the ethical issues and issues of individual privacy raised by the ability of biomedical researchers to study human biological materials. SuDoc number: PREX 1.19:B 52/ET 3/EXEC.SUM SuDoc number: PREX 1.19:B 52/ET 3/V.1 Online version: http://purl.access.gpo.gov/GPO/LPS26174 SuDoc number: PREX 1.19:B 52/ET 3/V.2 Online version: http://purl.access.gpo.gov/GPO/LPS26175 |
| 7. Ethical and Policy Issues
in International Research : Clinical Trials in Developing Countries (2001) (Two volumes plus an Executive Summary) This report by the National Bioethics Advisory Commission addresses the ethical issues surrounding the conduct of clinical trials conducted by U.S. interests abroad. SuDoc number: PREX 1.19:B 52/ET 3/2/EXEC.SUM SuDoc number: PREX 1.19:B 52/ET 3/2/V.1 Online version: http://purl.access.gpo.gov/GPO/LPS11823 SuDoc number: PREX 1.19:B 52/ET 3/2/V.2 Online version: http://purl.access.gpo.gov/GPO/LPS11824 |
| 8. Ethical Issues in Human Stem
Cell Research (1999) Three volumes (volume 3 issued in an online version only). This report by the National Bioethics Advisory Commission addresses the ethical issues relevant to federal sponsorship of research involving human embryonic stem cells and embryonic germ cells. SuDoc number: PREX 1.19:ST 4/ET 3/2/V.1 Online version: http://purl.access.gpo.gov/GPO/LPS101486 SuDoc number: PREX 1.19:ST 4/ET 3/2/V.2 Online version: http://purl.access.gpo.gov/GPO/LPS10147 Online version (volume 3): http://purl.access.gpo.gov/GPO/LPS10148 |
| 9. Biotechnology for the 21st
Century (1992) This report, prepared by the Committee on Life Sciences and Health of the Federal Coordinating Council for Science, Engineering and Technology, outlines a coordinated interagency effort to develop and implement a national Biotechnology Research Program. SuDoc number: PREX 8.111/2:993 |
| 10. Biotechnology for the 21st
Century: Realizing the Promise (1993) This report, prepared by the Committee on Life Sciences and Health of the Federal Coordinating Council for Science, Engineering and Technology, analyzes different federal agencies’ biotechnology research programs in three categories: research, social impact research and infrastructure. SuDoc number: PREX 8.111/2:993/SUPP. |
| 10. Biotechnology for the 21st
Century: Realizing the Promise (1993) This report, prepared by the Committee on Life Sciences and Health of the Federal Coordinating Council for Science, Engineering and Technology, analyzes different federal agencies’ biotechnology research programs in three categories: research, social impact research and infrastructure. SuDoc number: PREX 8.111/2:993/SUPP. |
| 11. Biotechnology for the 21st
Century: New Horizons (1995) This report highlights ongoing federal research efforts in biotechnology and identifies areas where there might be gaps in federal support. SuDoc number: PREX 8.111/2:995 Online version: http://purl.access.gpo.gov/GPO/LPS6161 |
| 12. A New Technological Era
for American Agriculture (1992) A report that analyzes the effects of emerging technologies on the agriculture industry, including an assessment of adjustments that industry must make to capitalize on the new technologies, the scientific and institutional issues relevant to food safety and environmental risk and benefit, and the implications for intellectual property rights and science policy. SuDoc number (Full report): Y 3.T 22/2:2 AG 8/6 SuDoc number (Summary): Y 3.T 22/2:2 AG 8/6/SUM. |
| 13. Biology, Medicine, and the
Bill of Rights (1988) This report considers the implications of new developments in biological sciences for the freedoms and protections embedded in our Bill of Rights. SuDoc number: Y 3.T 22/2:2 B 52/5 |
| 14. Biotechnology in a Global
Economy (1991) This report examines the impact of biotechnology in several industries, including pharmaceuticals, chemicals, agriculture, and hazardous waste clean-up; the efforts of 16 nations to develop commercial uses of biotechnology; and the actions, both direct and indirect, taken by various governments that influence innovation in biotechnology. SuDoc number: Y 3.T 22/2:2 B 57/9 |
| 15. Biomedical Ethics in U.S.
Public Policy (1993) This background paper reviews the history of four Federal bioethics initiatives in the context of the question: If Congress decides to create a new Federal bioethics body, what does past experience reveal about which particular factors promote success and which should be avoided? SuDoc number: Y 3.T 22/2:2 B 52/ |
| 16. Biopolymers: Making Materials
Nature’s Way (1993) This study provides a basic introduction to biopolymer technology, profiles some of the more promising polymer materials, reviews research activities in the United States, Europe and Japan, and describes the principal technical challenges and regulatory issues that may affect biopolymer commercialization efforts. SuDoc number: Y 3.T 22/2:2 B 52/10 |
| 17. New Developments in Biotechnology:
Ownership of Human Tissues and Cells (1987) This report analyzes the economic, legal and ethical rights of the human sources of tissues and cells and also those of the physicians or researchers who obtain and develop these biological materials. SuDoc number: Y 3.T 22/2:2 B 52/4/V.1 |
| 18. New Developments in Biotechnology:
Public Perceptions of Biotechnology (1987) This paper reports the results of a nationwide survey of public knowledge and opinion about issues concerning science and technology in general and genetic engineering and biotechnology in particular. The willingness of the American people to accept risks in return for benefits of scientific innovation is assessed, as well as the public’s reaction to testing genetically engineered organisms in their own community and to human gene therapy. SuDoc number: Y 3.T 22/2:2 B 52/4/V.2 |
| 19. New Developments in Biotechnology:
Field-Testing Engineered Organisms: Genetic and Ecological Issues (1988) This report analyzes some of the scientific and public opinion issues surrounding the planned introduction of genetically engineered organisms into the environment, and illustrates a range of options for congressional action in three major areas of public policy: • the criteria for review of planned introductions for potential risk, • the administrative mechanisms for applying such review criteria • the research base supporting planned introductions. SuDoc number: Y 3.T 22/2:2 B 52/4/V.3 |
| 20. New Developments in Biotechnology:
U.S. Investment in Biotechnology (1988) This report describes the levels and types of investment currently being made by the Federal, State and private sectors. 10 major issues that affect investment were identified: levels of R & D funding, research priorities, interagency coordination, information requirements, training and education needs, monitoring of university-industry research, state efforts to promote biotechnology, the effects of tax law on commercial biotechnology, the adequacy of Federal assistance for biotechnology start-ups and the effects of export control on biotechnology commerce. SuDoc number: Y 3.T 22/2:2 B 52/4/V.4 SuDoc number (Summary): Y 3.T 22/2:2 B 52/4/V.4/SUM. |
| 21. New Developments in Biotechnology:
Patenting Life (1989) This report reviews U.S. patent law as it relates to the patentability of micro-organisms, cells, plants and animals; as well as specific areas of concern, including deposit requirements and international considerations. The report includes a range of options for congressional action related to the patenting of animals, intellectual property protection for plants, and enablement of patents involving biological material. SuDoc number: Y 3.T 22/2:2 B 52/4/V.5 |
| 22. The Future of Food: Biotechnology
and Consumer Confidence (2000) This Senate hearing examines the issues related to biotechnology and genetically engineered food, and the measures needed to ensure consumer safety and confidence with respect to these food products. SuDoc number: Y 4.L 11/4:S.HRG.106-698 |
| 23. The Human Cloning Prohibition
Act of 2001 and the Cloning Prohibition Act of 2001 (2001) This House hearing considers two bills introduced into the House of Representatives: H.R. 1644, which seeks to ban the creation of cloned human embryos, and H.R. 2172 which seeks to prevent those who clone human embryos from implanting them in a surrogate mother. SuDoc number: Y 4.C 73/8:107-41 Online (HTML) version: http://purl.access.gpo.gov/GPO/LPS15808 Online (PDF) version: http://purl.access.gpo.gov/GPO/LPS15809 |
| 24. The Dangers of Cloning and
the Promise of Regenerative Medicine (2002) This Senate hearing examines cloning research, focusing on the clarification of how stem cell research, or therapeutic cloning, differs from human reproductive cloning, and the ethical and public policy issues related to both, and related to the Senate bill S. 1853, which seeks to ban human cloning while protecting stem cell research. SuDoc number: Y 4.L 11/4:S.HRG.107-497 |
| 25. Office of Biotechnology
Activities, National Institutes of Health (Web Site) The Office of Biotechnology Activities monitors scientific progress in human genetics research in order to anticipate future developments, including ethical, legal, and social concerns, in basic and clinical research involving Recombinant DNA, Genetic Testing, and Xenotransplantation. Web Site URL: http://www4.od.nih.gov/oba/ |
| 26. National Center for Biotechnology
Information (Web Site) The National Center for Biotechnology Information creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information. Web Site URL: http://www.ncbi.nlm.nih.gov/ |
| 27. Global Issues: Biotechnology
(Web Site) The Office of International Information Programs of the U.S. Department of State provides products and services that explain U.S. policies, society, and values to foreign audiences. The Office publishes five electronic journals, including this one, Global Issues. This journal provides statements of U.S. policy together with analysis, commentary, and background information on a variety of issues, including biotechnology. Web Site URL: http://usinfo.state.gov/topical/global/biotech/ |
| 28. Agricultural Biotechnology
(Web Site) This web site contains detailed information on how the USDA Animal and Plant Health Inspection Service (APHIS) regulates the movement, importation, and field testing of genetically engineered plants and microorganisms through permitting and notification procedures. Web Site URL: http://www.aphis.usda.gov/ppq/biotech/ |
